RxDoctor Payments DataLook up a doctor →

OBIZUR: payments to doctors

Payments that named OBIZUR as the associated drug or biological, reported under the Sunshine Act for program years 20192025.

Total reported
$11.8M
Providers
70
Transactions
153
Average per transaction
$77,160

The per-transaction average — $77,160 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 70 providers the average total is $168,650, but that average hides a very steep distribution.

Companies reporting these payments

CompanyTotal reportedShare
Takeda Pharmaceuticals U.S.A., Inc.$9,771,22182.8%
Shire North American Group Inc$2,034,26517.2%
← All drugs & devices